Corbus Pharmaceuticals Holdings (CRBP) Free Cash Flow Growth (1y) (2014 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) Free Cash Flow Growth (1y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 60.84% |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 88.70% |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -15.72% |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 66.37% |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Corbus Pharmaceuticals Holdings | 135.08 Mn | 107.27 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -11.53% |
| Jun 30, 2025 | -85.61% |
| Mar 31, 2025 | -106.11% |
| Dec 31, 2024 | -82.12% |
| Sep 30, 2024 | -94.29% |
| Jun 30, 2024 | -14.64% |
| Mar 31, 2024 | 47.29% |
| Dec 31, 2023 | 19.41% |
| Sep 30, 2023 | 0.95% |
| Jun 30, 2023 | 36.21% |
| Mar 31, 2023 | -42.21% |
| Dec 31, 2022 | 23.59% |
| Sep 30, 2022 | -945.44% |
| Jun 30, 2022 | 30.23% |
| Mar 31, 2022 | 51.27% |
| Dec 31, 2021 | 46.31% |
| Sep 30, 2021 | 103.14% |
| Jun 30, 2021 | 34.16% |
| Mar 31, 2021 | 22.29% |
| Dec 31, 2020 | 23.82% |